Polak M, Leger J, Luton D, Oury J F, Vuillard E, Boissinot C, Czernichow P
Department of Paediatric Endocrinology and Diabetology, Hôpital Robert Debré, Paris.
Ann Endocrinol (Paris). 1997;58(4):338-42.
We described here three individual pregnancies in a euthyroid mother with a past history of Graves disease and high levels of thyrotropin receptor stimulating antibodies. Ten years prior to her first pregnancy the mother underwent a partial thyroidectomy for Graves disease and remained euthyroid since, but still produced high levels of thyrotropin receptor stimulating antibodies. Fetal and postnatal hyperthyroidism was not recognized for the first child who was referred to us at one year of age for craniostenosis. During the two next pregnancies fetal hyperthyroidism was suspected on the basis of fetal tachycardia, growth retardation, fetal goiter and fetal cord blood sampling confirmed high levels of free T3, free T4, suppressed fetal TSH levels, and high levels of fetal TRAb. The mother received propylthiouracil to control fetal hyperthyroidism. Neither baby was premature and each had a more favorable outcome than the first. Fetal cord blood sampling proved to be useful during these two pregnancies to ascertain the diagnosis of fetal hyperthyroidism and to monitor the dose of PTU administered to this euthyroid mother.
我们在此描述了一位甲状腺功能正常的母亲的三次妊娠情况,该母亲既往有格雷夫斯病病史,促甲状腺素受体刺激抗体水平较高。在她首次怀孕前十年,母亲因格雷夫斯病接受了部分甲状腺切除术,此后一直甲状腺功能正常,但仍产生高水平的促甲状腺素受体刺激抗体。第一个孩子一岁时因颅骨狭窄被转诊至我们这里,当时未发现胎儿和产后甲状腺功能亢进。在接下来的两次妊娠中,根据胎儿心动过速、生长发育迟缓、胎儿甲状腺肿大怀疑胎儿甲状腺功能亢进,胎儿脐血采样证实游离T3、游离T4水平升高,胎儿促甲状腺激素水平受抑制,胎儿促甲状腺素受体抗体水平升高。母亲接受丙硫氧嘧啶来控制胎儿甲状腺功能亢进。两个婴儿均未早产,且每个婴儿的结局都比第一个婴儿更好。在这两次妊娠期间,胎儿脐血采样被证明有助于确定胎儿甲状腺功能亢进的诊断,并监测给予这位甲状腺功能正常母亲的丙硫氧嘧啶剂量。